Clinical Trial Update: HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing once-daily versus twice-daily protease inhibitor therapy in antiretroviral treatment-naive adults with HIV-1 infection has completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Protease inhibitor regimen (once-daily vs twice-daily)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus I, HIV-1 Infection | Phase 3 | Status: COMPLETED | Results posted: 2009-09-02